Literature DB >> 15817713

Attempted replication of reported chronic obstructive pulmonary disease candidate gene associations.

Craig P Hersh1, Dawn L Demeo, Christoph Lange, Augusto A Litonjua, John J Reilly, David Kwiatkowski, Nan Laird, Jody S Sylvia, David Sparrow, Frank E Speizer, Scott T Weiss, Edwin K Silverman.   

Abstract

Case-control studies have successfully identified many significant genetic associations for complex diseases, but lack of replication has been a criticism of case-control genetic association studies in general. We selected 12 candidate genes with reported associations to chronic obstructive pulmonary disease (COPD) and genotyped 29 polymorphisms in a family-based study and in a case-control study. In the Boston Early-Onset COPD Study families, significant associations with quantitative and/or qualitative COPD-related phenotypes were found for the tumor necrosis factor (TNF)-alpha -308G>A promoter polymorphism (P < 0.02), a coding variant in surfactant protein B (SFTPB Thr131Ile) (P = 0.03), and the (GT)(31) allele of the heme oxygenase (HMOX1) promoter short tandem repeat (P = 0.02). In the case-control study, the SFTPB Thr131Ile polymorphism was associated with COPD, but only in the presence of a gene-by-environment interaction term (P = 0.01 for both main effect and interaction). The 30-repeat, but not the 31-repeat, allele of HMOX1 was associated (P = 0.04). The TNF -308G>A polymorphism was not significant. In addition, the microsomal epoxide hydrolase "fast" allele (EPHX1 His139Arg) was significantly associated in the case-control study (P = 0.03). Although some evidence for replication was found for SFTPB and HMOX1, none of the previously published COPD genetic associations was convincingly replicated across both study designs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15817713      PMCID: PMC2715305          DOI: 10.1165/rcmb.2005-0073OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  32 in total

1.  Association mapping in structured populations.

Authors:  J K Pritchard; M Stephens; N A Rosenberg; P Donnelly
Journal:  Am J Hum Genet       Date:  2000-05-26       Impact factor: 11.025

Review 2.  Case-control association studies for the genetics of complex respiratory diseases.

Authors:  E K Silverman; L J Palmer
Journal:  Am J Respir Cell Mol Biol       Date:  2000-06       Impact factor: 6.914

3.  Susceptibility genes for rapid decline of lung function in the lung health study.

Authors:  A J Sandford; T Chagani; T D Weir; J E Connett; N R Anthonisen; P D Paré
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

4.  A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS.

Authors:  X Sun; H Ding; K Hung; B Guo
Journal:  Nucleic Acids Res       Date:  2000-06-15       Impact factor: 16.971

5.  Genetic susceptibility to chronic obstructive pulmonary disease in Koreans: combined analysis of polymorphic genotypes for microsomal epoxide hydrolase and glutathione S-transferase M1 and T1.

Authors:  J J Yim; G Y Park; C T Lee; Y W Kim; S K Han; Y S Shim; C G Yoo
Journal:  Thorax       Date:  2000-02       Impact factor: 9.139

6.  Microsatellite polymorphism in the heme oxygenase-1 gene promoter is associated with susceptibility to emphysema.

Authors:  N Yamada; M Yamaya; S Okinaga; K Nakayama; K Sekizawa; S Shibahara; H Sasaki
Journal:  Am J Hum Genet       Date:  2000-01       Impact factor: 11.025

7.  Rationale and design of The National Emphysema Treatment Trial: a prospective randomized trial of lung volume reduction surgery. The National Emphysema Treatment Trial Research Group.

Authors: 
Journal:  Chest       Date:  1999-12       Impact factor: 9.410

8.  The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes.

Authors:  D Altshuler; J N Hirschhorn; M Klannemark; C M Lindgren; M C Vohl; J Nemesh; C R Lane; S F Schaffner; S Bolk; C Brewer; T Tuomi; D Gaudet; T J Hudson; M Daly; L Groop; E S Lander
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

9.  Gender-related differences in severe, early-onset chronic obstructive pulmonary disease.

Authors:  E K Silverman; S T Weiss; J M Drazen; H A Chapman; V Carey; E J Campbell; P Denish; R A Silverman; J C Celedon; J J Reilly; L C Ginns; F E Speizer
Journal:  Am J Respir Crit Care Med       Date:  2000-12       Impact factor: 21.405

10.  Association of tumor necrosis factor alpha gene promoter polymorphism with the presence of chronic obstructive pulmonary disease.

Authors:  S Sakao; K Tatsumi; H Igari; Y Shino; H Shirasawa; T Kuriyama
Journal:  Am J Respir Crit Care Med       Date:  2001-02       Impact factor: 21.405

View more
  68 in total

1.  Glutathione S-transferase M1 and T1 gene polymorphism and COPD risk in smokers: an updated analysis.

Authors:  Hong Xue; Jian Su; Kai Sun; Weiping Xie; Hong Wang
Journal:  Mol Biol Rep       Date:  2011-12-09       Impact factor: 2.316

2.  Identification of a chronic obstructive pulmonary disease genetic determinant that regulates HHIP.

Authors:  Xiaobo Zhou; Rebecca M Baron; Megan Hardin; Michael H Cho; Jan Zielinski; Iwona Hawrylkiewicz; Pawel Sliwinski; Craig P Hersh; John D Mancini; Ke Lu; Derek Thibault; Amy L Donahue; Barbara J Klanderman; Bernard Rosner; Benjamin A Raby; Quan Lu; Adriana M Geldart; Matthew D Layne; Mark A Perrella; Scott T Weiss; Augustine M K Choi; Edwin K Silverman
Journal:  Hum Mol Genet       Date:  2011-12-02       Impact factor: 6.150

Review 3.  Progress in chronic obstructive pulmonary disease genetics.

Authors:  Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2006-07

4.  Association of tumor necrosis factor-alpha-863C/A gene polymorphism with chronic obstructive pulmonary disease.

Authors:  Yung-Che Chen; Shih-Feng Liu; Chien-Hung Chin; Chao-Chien Wu; Chung-Jen Chen; Hsueh-Wen Chang; Yi-Hsi Wang; Yu-Hsiu Chung; Tung-Ying Chao; Meng-Chih Lin
Journal:  Lung       Date:  2010-03-30       Impact factor: 2.584

Review 5.  Genetics of complex respiratory diseases: implications for pathophysiology and pharmacology studies.

Authors:  Ma'en Obeidat; Ian P Hall
Journal:  Br J Pharmacol       Date:  2011-05       Impact factor: 8.739

6.  Vitamin D binding protein gene polymorphisms and chronic obstructive pulmonary disease: a meta-analysis.

Authors:  Huan Chen; Lei Zhang; Zhiyi He; Xiaoning Zhong; Jianquan Zhang; Meihua Li; Jing Bai
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 7.  National Emphysema Treatment Trial state of the art: genetics of emphysema.

Authors:  Craig P Hersh; Dawn L DeMeo; Edwin K Silverman
Journal:  Proc Am Thorac Soc       Date:  2008-05-01

Review 8.  Genetic variation and gene expression in antioxidant related enzymes and risk of COPD: a systematic review.

Authors:  A R Bentley; P Emrani; P A Cassano
Journal:  Thorax       Date:  2008-06-19       Impact factor: 9.139

Review 9.  Genetics of chronic obstructive pulmonary disease.

Authors:  Carola Seifart; Alexandra Plagens
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2007

10.  Level and course of FEV1 in relation to polymorphisms in NFE2L2 and KEAP1 in the general population.

Authors:  Mateusz Siedlinski; Dirkje S Postma; Jolanda M A Boer; Gerrit van der Steege; Jan P Schouten; Henriette A Smit; H Marike Boezen
Journal:  Respir Res       Date:  2009-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.